“Brentuximab Vedotin Effects on Prognosis of Refractory and Relapsed Peripheral T-Cell Lymphoma: A Systematic Review”. Revista de Medicina e Saúde de Brasília 7, no. 2 (January 5, 2019). Accessed September 27, 2026. https://ojs-test.siteworks.com.br/index.php/rmsbr/article/view/9251.